-
Subject Areas on Research
-
17th
Century Variola Virus Reveals the Recent History of Smallpox.
-
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.
-
Salmonella
Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses.
-
A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents.
-
A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus Macaques.
-
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.
-
A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.
-
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs.
-
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
-
A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program.
-
A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
-
A statement regarding personal belief exemption from immunization mandates: from the Pediatric Infectious Diseases Society, March 2011.
-
A systematic review of human papillomavirus vaccination among US adolescents.
-
A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center.
-
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
-
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
-
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
-
Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system.
-
Acute Corneal Transplant Rejection After COVID-19 Vaccination.
-
Adenovirus F protein as a delivery vehicle for botulinum B.
-
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
-
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.
-
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.
-
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity.
-
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
-
An economic framework for preventive care advice.
-
Analysis of Japanese encephalitis epidemic in Western Nepal in 1997.
-
Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response.
-
Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.
-
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
-
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
-
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.
-
Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.
-
Assessing university students' sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior.
-
Association Between Parental HPV Knowledge and Intentions to Have Their Daughters Vaccinated.
-
Association of State COVID-19 Vaccination Prioritization With Vaccination Rates Among Incarcerated Persons.
-
Association of vaccine-related attitudes and beliefs between parents and health care providers
-
Associations between obesity and receipt of screening mammography, Papanicolaou tests, and influenza vaccination: results from the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) Study.
-
Associations of health behaviors with human papillomavirus vaccine uptake, completion, and intentions among female undergraduate students.
-
Assortativity and Bias in Epidemiologic Studies of Contagious Outcomes: A Simulated Example in the Context of Vaccination.
-
Attitude, intention, and barriers toward influenza vaccination among pregnant women in South Korea
-
Attitudes and Beliefs of Patients With Left-Ventricular Assist Devices Toward COVID-19 Vaccination and Willingness to Seek Care During the Pandemic.
-
B cell responses to HIV-1 infection and vaccination: pathways to preventing infection.
-
B cell responses to the 2011/12-influenza vaccine in the aged.
-
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
-
BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine.
-
Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.
-
Beyond coverage: Rural-urban disparities in the timeliness of childhood vaccinations in Tanzania.
-
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.
-
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
-
Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
-
Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.
-
CD20 deficiency in humans results in impaired T cell-independent antibody responses.
-
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
-
COVID-19 Incidence Among Sixth Through Twelfth Grade Students by Vaccination Status.
-
COVID-19 Vaccination Rates in a Global HIV Cohort.
-
COVID-19 Vaccination and Obesity: Optimism and Challenges.
-
COVID-19 and VITT: same or different?
-
COVID-19 vaccination in individuals with spina bifida: A national survey.
-
COVID-19 vaccination in our transplant recipients: The time is now.
-
COVID-19 vaccination intention and activation among health care system employees: A mixed methods study.
-
COVID-19 vaccine hesitancy among low-income, racially and ethnically diverse US parents.
-
COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans.
-
CXCL13 is a plasma biomarker of germinal center activity.
-
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
-
Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
-
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
-
Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.
-
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge.
-
Childhood Pneumonia.
-
Childhood vaccine development: an overview.
-
Choice of Study Populations for Vaccines.
-
Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization.
-
Clinical applications of a peptide-based vaccine for glioblastoma.
-
Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
-
Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.
-
Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques.
-
Coincidence analysis: a new method for causal inference in implementation science.
-
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
-
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
-
Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.
-
Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.
-
Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge.
-
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
-
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
-
Control of meningococcal disease in west Africa.
-
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
-
Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
-
Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
-
Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
-
Cost-effectiveness evaluation of measles immunization strategies on a college campus.
-
Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
-
Cost-effectiveness of a potential vaccine for Coccidioides immitis.
-
Cost-effectiveness of a potential vaccine for human papillomavirus.
-
Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax.
-
Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
-
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.
-
Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
-
Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
-
Current immunotherapeutic strategies in colon cancer.
-
Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature.
-
Cytokines: the future of intranasal vaccine adjuvants.
-
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.
-
DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.
-
DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus.
-
DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.
-
DNA vaccination. A clue to memory?
-
DNA vaccines and immunity to herpes simplex virus.
-
DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.
-
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines.
-
Detection of bloodstream pathogens in a bacille Calmette-Guérin (BCG)-vaccinated pediatric population in Malawi: a pilot study.
-
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.
-
Determinants and Trends of COVID-19 Vaccine Hesitancy and Vaccine Uptake in a National Cohort of US Adults: A Longitudinal Study.
-
Developing an effective and sustainable national immunisation programme in China: issues and challenges.
-
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
-
Development of a vaccine for the prevention of AIDS, a critical appraisal.
-
Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
-
Digital health for real-time monitoring of a national immunisation campaign in Indonesia: a large-scale effectiveness evaluation.
-
Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity.
-
Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
-
Disparities in human papillomavirus (HPV) vaccine initiation and completion based on sexual orientation among women in the United States.
-
Disparities in preschool immunization coverage associated with maternal age
-
Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.
-
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects.
-
Do mobile phone-based reminders and conditional financial transfers improve the timeliness of childhood vaccinations in Tanzania? Study protocol for a quasi-randomized controlled trial.
-
Does Self-Efficacy Mediate the Relationships Between Social-Cognitive Factors and Intentions to Receive HPV Vaccination Among Young Women?
-
Does influenza vaccination or RSV prophylaxis impact resource utilization for children after the diagnosis of airway disorders?
-
Drinking Water to Prevent Postvaccination Presyncope in Adolescents: A Randomized Trial.
-
Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
-
Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques.
-
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.
-
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
-
Educational content and the effectiveness of influenza vaccination reminders.
-
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
-
Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial.
-
Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus.
-
Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination.
-
Effect of patient reminder/recall interventions on immunization rates: A review.
-
Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
-
Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.
-
Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women.
-
Effects of a randomized controlled trial of a brief, student-nurse led, parent-based sexual health intervention on parental protective factors and HPV vaccination uptake.
-
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.
-
Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.
-
Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status.
-
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines.
-
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.
-
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.
-
Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins.
-
Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins.
-
Enhancement of cancer radiation therapy by use of adenovirus-mediated secretable glucose-regulated protein 94/gp96 expression.
-
Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
-
Evaluating human papillomavirus vaccination programs.
-
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.
-
Evaluation of vaccine-induced antibody responses: impact of new technologies.
-
Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
-
Examining Associations between Knowledge and Vaccine Uptake Using the Human Papillomavirus Knowledge Questionnaire (HPV-KQ).
-
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.
-
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.
-
Factors Associated With Human Papillomavirus Vaccine Series Completion Among Adolescents.
-
Factors Associated With Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-Sectional Analysis.
-
Factors affecting influenza vaccination among attendees at a senior center.
-
Factors affecting vaccination demand in Indonesia: a secondary analysis and multimethods national assessment.
-
Family physician acceptance of universal hepatitis B immunization of infants.
-
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
-
Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001.
-
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
-
Fundamentals of Clinical Pharmacology With Application for Pregnant Women.
-
GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression.
-
Gene profiling of immune responses against tumors.
-
Genomic correlates of variability in immune response to an oral cholera vaccine.
-
Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S.
-
HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques.
-
HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy.
-
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.
-
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.
-
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge.
-
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
-
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.
-
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
-
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial.
-
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
-
HPV Vaccination Is Safe-You Don't Have to Whisper It.
-
Haemophilus influenzae type b infections in Victoria, Australia, 1985 to 1987.
-
Hepatitis B immunization: a potential incentive to HIV vaccine trial participation in Thailand?
-
Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis.
-
Hepatitis B vaccines in patients with chronic renal failure before dialysis.
-
Hepatitis B virus vaccine. An analysis of its potential use in medical workers.
-
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors.
-
High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination.
-
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
-
High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.
-
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.
-
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.
-
How Influenza Vaccination Rate Variation Could Inform Pandemic-Era Vaccination Efforts.
-
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.
-
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
-
Human Papillomavirus Vaccination Status and Parental Endorsement Intentions among Undergraduate Student Nurses.
-
Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US.
-
Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination.
-
Human papillomavirus vaccination uptake among Native Hawaiian and Pacific Islander adults in the United States.
-
Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008.
-
Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States.
-
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.
-
Hurdles to herd immunity: Distrust of government and vaccine refusal in the US, 2002-2003.
-
IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens.
-
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.
-
Immune checkpoint modulation enhances HIV-1 antibody induction.
-
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.
-
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
-
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
-
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.
-
Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.
-
Immune selection after antigen-specific immunotherapy of melanoma.
-
Immunization and MS: a summary of published evidence and recommendations.
-
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques.
-
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
-
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.
-
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.
-
Immunizations for preteens.
-
Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial.
-
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.
-
Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
-
Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
-
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
-
Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.
-
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.
-
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
-
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
-
Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.
-
Immunological properties of bacterial DNA.
-
Immunotherapy of surgical malignancies.
-
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection.
-
Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques.
-
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.
-
Impact of patient education on influenza vaccine uptake among community-dwelling elderly: a randomized controlled trial.
-
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
-
Impact of synchronized anti-PD-1 with Ad-CEA vaccination on inhibition of colon cancer growth.
-
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.
-
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
-
Improving Influenza Prevention: Modest Changes With Large Effects.
-
Improving adherence to hepatitis B vaccine administration recommendations in two newborn nurseries.
-
Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
-
Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development.
-
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
-
Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression.
-
Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
-
Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
-
Individual and Joint Effects of Influenza-Like Illness and Vaccinations on Stroke in the Young: A Case-Control Study: Can You Catch a Stroke?
-
Induction of immunity to human immunodeficiency virus type-1 by vaccination.
-
Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products.
-
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.
-
Infections in Pregnancy and the Role of Vaccines.
-
Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.
-
Influenza Adherence Tool Kit: Implementation and Evaluation Among Allogeneic Hematopoietic Transplantation Recipients
.
-
Influenza Vaccination in Patients With Heart Failure.
-
Influenza and Antibody-Dependent Cellular Cytotoxicity.
-
Influenza vaccination in children with neurologic or neurodevelopmental disorders.
-
Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates.
-
Informed consent and investigational new drug abuses in the U.S. military.
-
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
-
Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine.
-
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus).
-
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.
-
Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials.
-
Intranasal delivery of an adjuvanted modified live porcine reproductive and respiratory syndrome virus vaccine reduces ROS production.
-
Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs.
-
Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses.
-
Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue.
-
Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.
-
Is developing an HIV-1 vaccine possible?
-
Isolated abducens nerve palsy following neonatal hepatitis B vaccination.
-
Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina.
-
Key stakeholder perspectives on challenges and opportunities for rural HPV vaccination in North and South Carolina.
-
Lack of effectiveness of a letter reminder for annual influenza immunization of asthmatic children.
-
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.
-
Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.
-
Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
-
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.
-
Long-term persistence of zoster vaccine efficacy.
-
Longitudinal multi-omics of host-microbe dynamics in prediabetes.
-
Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center.
-
MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group.
-
Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria.
-
Malaria vaccine trials in pregnant women: An imperative without precedent.
-
Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19.
-
Mapping routine measles vaccination in low- and middle-income countries.
-
Mast cell-orchestrated immunity to pathogens.
-
Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy.
-
Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries.
-
Maternal determinants of timely vaccination coverage among infants in rural Bangladesh.
-
Maternal immune protection against infectious diseases.
-
Maternal immunisation and neonatal infection of hepatitis A or B virus - Authors' reply.
-
Maternal immunisation to improve the health of HIV-exposed infants.
-
Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.
-
Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
-
Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States.
-
Medicine. The need for a global HIV vaccine enterprise.
-
Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
-
Meningococcal immunisation in Ghana.
-
Missed opportunities for adolescent vaccination, 2006-2011.
-
Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
-
Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).
-
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.
-
Modified varicella-like syndrome in children previously vaccinated with live attenuated measles, mumps, rubella and varicella vaccine.
-
Modulation of alloimmunity to major histocompatibility complex class I by cotransfer of cytokine genes in vivo.
-
Modulation of specific active immunization against murine melanoma using recombinant cytokines.
-
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1.
-
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
-
Multifactorial influences underpinning a decision on COVID-19 vaccination among healthcare workers: a qualitative analysis.
-
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
-
Myocarditis Temporally Associated With COVID-19 Vaccination.
-
NLRC3 expression in dendritic cells attenuates CD4+ T cell response and autoimmunity.
-
Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
-
Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.
-
National COVID-19 vaccination plan: using artificial spatial intelligence to overcome challenges in Brazil.
-
Navigating parental vaccine hesitancy.
-
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
-
Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus.
-
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
-
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
-
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.
-
Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence
-
Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.
-
Not just a woman's business! Understanding men and women's knowledge of HPV, the HPV vaccine, and HPV-associated cancers.
-
Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination.
-
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
-
Obesity Dysregulates the Immune Response to Influenza Infection and Vaccination Through Metabolic and Inflammatory Mechanisms.
-
On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes.
-
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses.
-
Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector.
-
Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.
-
Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques.
-
Oral immunogenicity of the plant proteinase bromelain.
-
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.
-
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model.
-
Parental concerns and uptake of childhood vaccines in rural Tanzania - a mixed methods study.
-
Parental vaccine concerns in Kentucky.
-
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.
-
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
-
Patients With Myocarditis Associated With COVID-19 Vaccination.
-
Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells.
-
Perceptions of Glove Use During Vaccination: A Cross-Sectional Study.
-
Perceptions of personal belief vaccine exemption policy: a survey of Arizona vaccine providers.
-
Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster Vaccine.
-
Persistence of antibody in healthcare workers vaccinated against hepatitis B.
-
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.
-
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination.
-
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected].
-
Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
-
Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.
-
Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma.
-
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.
-
Pneumococcal Carriage and Vaccine Coverage in Retirement Community Residents.
-
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.
-
Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.
-
Positive antibody response to vaccination in adolescence predicts lower C-reactive protein concentration in young adulthood in the Philippines.
-
Postpartum immunization. Report of a study.
-
Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.
-
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
-
Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S.
-
Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.
-
Potential leukemia virus subunit vaccines: discussion.
-
Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.
-
Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy.
-
Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states.
-
Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.
-
Predictors of willingness to get a COVID-19 vaccine in the U.S.
-
Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial.
-
Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.
-
Preventive care in relation to obesity: an analysis of a large, national survey.
-
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.
-
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
-
Private demand for cholera vaccines in Beira, Mozambique.
-
Programmatic challenges in obtaining and confirming the pneumococcal vaccination status of cochlear implant recipients.
-
Promoting Strategies to Increase HPV Vaccination in the Pediatric Primary Care Setting.
-
Promoting Vaccine Confidence.
-
Prospects for a safe COVID-19 vaccine.
-
Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates.
-
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
-
Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein.
-
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies.
-
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors.
-
Proteomic and immunologic analyses of brain tumor exosomes.
-
Provider response and follow-up to parental declination of HPV vaccination.
-
Provider-level rates of HEDIS-consistent HPV vaccination in a regional health plan.
-
Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.
-
Quantifying the impact of accessibility on preventive healthcare in sub-Saharan Africa using mobile phone data.
-
RNA Vaccination Therapy: Advances in an Emerging Field.
-
Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period.
-
Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations.
-
Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.
-
Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022.
-
Recall of B cell memory depends on relative locations of prime and boost immunization.
-
Receipt of Recommended Adolescent Vaccines Among Youth With Special Health Care Needs.
-
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
-
Recent changes in vaccination guidelines. An update on vaccines and target population initiatives.
-
Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
-
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.
-
Reduction of peak viremia by an integration-defective SIV proviral DNA vaccine in rhesus macaques.
-
Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts.
-
Relational Mobility Predicts Faster Spread of COVID-19: A 39-Country Study.
-
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
-
Reply: Vaccination in Patients With Heart Failure: An Established Recommendation in Patients With Chronic Heart Disease.
-
Research on vaccines during pregnancy: protocol design and assessment of safety.
-
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments.
-
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
-
Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
-
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
-
Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.
-
Robust antibody and cellular responses induced by DNA-only vaccination for HIV.
-
SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy.
-
SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia.
-
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
-
SARS-CoV-2 vaccine acceptability among caregivers of childhood cancer survivors.
-
Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4-6 Years of Age.
-
Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.
-
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.
-
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.
-
Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
-
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
-
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.
-
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.
-
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
-
Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
-
Seasonal and novel H1N1 influenza vaccination at a children's hospital.
-
Self-efficacy and HPV Vaccine Attitudes Mediate the Relationship Between Social Norms and Intentions to Receive the HPV Vaccine Among College Students.
-
Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.
-
Shigellosis in custodial institutions.
-
Simian immunodeficiency virus DNA vaccine trial in macaques.
-
Simian immunodeficiency virus DNA vaccine trial in macaques.
-
Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
-
Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques.
-
Softness makes it better.
-
Some state vaccination laws contribute to greater exemption rates and disease outbreaks in the United States.
-
Splenectomy as a Destination: Improving Quality of Care Among Asplenic Veterans Through a Travel Clinic.
-
Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection.
-
Standard definitions of adherence for infrequent yet repeated health behaviors.
-
Strategies for eliciting HIV-1 inhibitory antibodies.
-
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination.
-
Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection.
-
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
-
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.
-
Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancer.
-
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
-
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
-
Support for immunization registries among parents of vaccinated and unvaccinated school-aged children: a case control study.
-
Survivors of childhood cancer: an Australian audit of vaccination status after treatment.
-
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
-
Systems biology of vaccination for seasonal influenza in humans.
-
Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine.
-
Technology evaluation: CEA-TRICOM, Therion Biologics Corp.
-
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
-
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway.
-
The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.
-
The HIV-positive traveler.
-
The HPV vaccine: are dosing recommendations being followed?
-
The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans.
-
The Rapid Evaluation of COVID-19 Vaccination in Emergency Departments for Underserved Patients Study.
-
The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
-
The economic impact of HPV vaccines: not just cervical cancer.
-
The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.
-
The effect of patient education on pediatric immunization rates.
-
The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged.
-
The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
-
The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy.
-
The need for inclusion of pregnant women in COVID-19 vaccine trials.
-
The origins and genomic diversity of American Civil War Era smallpox vaccine strains.
-
The quest for an antibody-based HIV vaccine.
-
The responsibilities of medical students in providing advice on the COVID-19 vaccination programme.
-
The role of anticipated regret and health beliefs in HPV vaccination intentions among young adults.
-
The role of bacterial DNA in autoantibody induction.
-
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
-
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
-
Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy.
-
Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination.
-
Timing of retroviral infection influences anamnestic immune response in vaccinated primates.
-
Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis.
-
Toward Optimal Communication About HPV Vaccination for Preteens and Their Parents: Evaluation of an Online Training for Pediatric and Family Medicine Health Care Providers.
-
Toward a vaccine against AIDS: rationale and current progress.
-
Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.
-
Travelers with sickle cell disease.
-
Trends in Otitis Media and Myringotomy With Tube Placement Among American Indian and Alaska Native Children and the US General Population of Children After Introduction of the 13-valent Pneumococcal Conjugate Vaccine.
-
Tumor-dendritic cell fusion as a basis for cancer immunotherapy.
-
Understanding COVID-19 vaccine uptake during pregnancy: 'Hesitance', knowledge, and evidence-based decision-making.
-
Update on immunizations in adults.
-
Use of mobile phones for improving vaccination coverage among children living in rural hard-to-reach areas and urban streets of Bangladesh.
-
Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.
-
Vaccinating Health Care Employees - Do They All Deserve Early Access?
-
Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure.
-
Vaccination after spleen embolization: A practice management guideline from the Eastern Association for the Surgery of Trauma.
-
Vaccination against Herpes Zoster and Postherpetic Neuralgia.
-
Vaccination against herpes zoster in developed countries: state of the evidence.
-
Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection.
-
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.
-
Vaccination establishes clonal relatives of germinal center T cells in the blood of humans.
-
Vaccination induces HIV broadly neutralizing antibody precursors in humans.
-
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network.
-
Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge.
-
Vaccination to Prevent Cancer.
-
Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models.
-
Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
-
Vaccination with T cell-defined antigens.
-
Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.
-
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates.
-
Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge.
-
Vaccinations for pregnant women.
-
Vaccine Development: Steps to Approval of an Investigational Vaccine.
-
Vaccine Hesitancy in North Carolina: The Elephant in the Room?
-
Vaccine Hesitancy in Rural Pediatric Primary Care.
-
Vaccine hesitancy in Indonesia.
-
Vaccine immunogenicity in injecting drug users: a systematic review.
-
Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.
-
Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children
-
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.
-
Vaccine safety: medical contraindications, myths, and risk communication.
-
Vaccine-based immunotherapeutic approaches to gliomas and beyond.
-
Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.
-
Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways.
-
Vaccine-preventable diseases in pregnancy.
-
Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children.
-
Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.
-
Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
-
Viral infections after renal transplantation.
-
What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Breaking through Immunity's Glass Ceiling.
-
When Should Patients Receive Mask Exemptions During the COVID-19 Pandemic? Ethics in Practice: Point-Counterpoint.
-
Who will enroll? Predicting participation in a phase II AIDS vaccine trial.
-
Workshop on immunizations in older adults: identifying future research agendas.
-
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.
-
[Vaccination of children. A resounding success from the 1980's].
-
Keywords of People
-
-
Ferrari, Guido,
Professor in Surgery,
Molecular Genetics and Microbiology
-
Gunn, Michael Dee,
Professor of Medicine,
Immunology
-
McLendon, Roger Edwin,
Professor of Pathology,
Pathology
-
Sampson, John Howard,
Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine,
Biomedical Engineering
-
Staats, Herman Ford,
Professor of Pathology,
Immunology
-
Weinhold, Kent James,
Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery,
Immunology
-
Yancy Jr., William Samuel,
Professor of Medicine,
Medicine, General Internal Medicine